.

.

SHARE PRICE 409.66

........

Asking you to double-check my work and answer the blanks and ratio please. and explain. Thank you

........

Part 1 The Price to Earnings Ratio (using GAAP earnings) FULL YEAR RESULT 2021

Net Income attributable to common stockholders	671,527
Weighted-average shares used in computing net income per share attributable to common stockholders: Basic	283,853,654
Net income per share	2.37
Price to earnings ratio	?

Complete the blanks in the following statement below. The statement, worded correctly, would represent one possible way of interpreting the Price to Earnings ratio which you calculated. (Hint: For the first blank, remember where the stock price came from).

1. The ______ is placing a value of _____ for each dollar of ___ ______ which ____ generated in fiscal 2021.

.

Part 2 The Price to Earnings Ratio (using Non-GAAP earnings) FULL YEAR RESULT 2021

Non-GAAP net income	995,738
Non-GAAP weighted-average shares are used to compute net income per share-basic	283,853,654
Non-GAAP net income per share	3,51
Price to Non-GAAP earnings ratio	?

Complete the blanks in the following statement below. The statement, worded correctly, would represent a way of interpreting the Price to Non-GAAP earnings ratio which you calculated.

2. The ______ is placing a value of _____ for each dollar of ___-____ earnings which ____ generated in fiscal 2021.

.

Part 3 The Price to Revenue Ratio

Revenue	2,651,368
Weighted-average shares used in computing net income per share attributable to common stockholders: Basic	283,853,654
Revenue per share	?
Price to revenue ratio	?

Complete the blanks in the following statement below. The statement, worded correctly, would represent a way of interpreting the Price to revenue ratio which you calculated.

3. The ______ is placing a value of _____ for each dollar of ______ which ____ generated during fiscal 2021.

.

Part 4 The Price to Research and Development Expense Ratio

Research and Development Expense	164,080
Weighted-average shares used in computing net income per share attributable to common stockholders: Basic	283,853,654
Research and Development expense per share	?
Price to research and development expense ratio	?

Complete the blanks in the following statement below. The statement, worded correctly, would represent a way of interpreting the Price to research and development expense ratio which you calculated.

4. The ______ is placing a value of _____ for each dollar of _______ and _________ ______ which ____ incurred during fiscal 2021.

Consolidated Statements of Operations (Unaudited, in thousands, except share and per share amounts) Three Months Ended January 31, 2021 2020 882,485 $ 188,251 267,284 32,547 615,201 155,704 Revenue $ $ Year Ended January 31, 2021 2020 2,651,368 $ 622,658 821,989 115,396 1,829,379 507,262 Cost of revenue Gross profit Operating expenses: Research and development Sales and marketing General and administrative Total operating expenses Income from operations Interest income and other, net Income before provision for (benefit from) income taxes Provision for (benefit from) income taxes Net income Undistributed earnings attributable to participating securities Net income attributable to common stockholders 52,375 214,018 92,691 359,084 256,117 8,536 264,653 4,043 260,610 (217) 260,393 20,669 100,905 23,577 145,151 10,553 3,992 14,545 (794) 15,339 (26) 15,313 164,080 684,904 320,547 1,169,531 659,848 18,186 678,034 5,718 67,079 340,646 86,841 494,566 12,696 13,666 26,362 1,057 25,305 (3,555) 21,750 672,316 (789) 671,527 $ $ $ $ Net income per share attributable to common stockholders: Basic $ 0.91 $ 0.06 $ 2.37 $ 0.09 $ 0.87 $ 0.05 $ 2.25 $ 0.09 Diluted Weighted average shares used in computing net income per share attributable to common stockholders: Basic Diluted 287,598,299 276,719,764 292,789,235 283,853,654 298,127,669 233,641,336 254,298,014 300,613,251 Consolidated Statements of Cash Flows (Unaudited, in thousands) ) Three months Ended January 31, 2021 2020 Year Ended January 31, 2021 2020 $ 260,610 $ 15,339 $ 672,316 25,305 96,261 33,025 11,789 9,456 26.577 11,162 2.394 275 818 104,306 32,007 28,857 23,312 10.887 3,822 73,109 37,101 6,370 16,449 4,860 3,705 2,643 2,045 509 6,885 11,068) (28,922) (20,263) (40,774) (5,292) 47,735 32,124 12.701) 399,396 (27,829) (2,366) (21,890) 1912) 12.306) 29,707 (736) 36,554 (219,039) (68,521) (307,068) 3,481 251,654 665,724 (6.379) 1,471.177 164,715) (24,805) (72,714) (2,030) 51,179 106,286 15,460) 151,892 Cash flows from operating activities: Net income Adjustments to reconcile net income to net cash provided by operating activities: Stock-based compensation expense Amortization of deferred contract acquisition costs Provision for accounts receivable allowances Depreciation and amortization Charitable donation of common stock Non-cash operating lease cost Other Changes in operating assets and liabilities: Accounts receivable Prepaid expenses and other assets Deferred contract acquisition costs Accounts payable Accrued expenses and other liabilities Deferred revenue Operating lease liabilities, net Net cash provided by operating activities Cash flows from investing activities: Purchases of marketable securities Maturities of marketable securities Sales of marketable securities Purchases of property and equipment Cash paid for acquisition, net of cash acquired Purchase of equity investment Purchases of intangible assets Purchase of convertible promissory note Other Net cash used in investing activities Cash flows from financing activities: Proceeds from follow-on offering, net of underwriting discounts and commissions and other offering costs Proceeds from issuance of common stock for employee stock purchase plan Proceeds from exercise of stock options, net of repurchases Proceeds from employee equity transactions to be remitted to employees and tax authorities, net Proceeds from initial public offering and private placement, net of underwriting discounts and commissions and other offering costs Net cash provided by financing activities Net increase in cash, cash equivalents, and restricted cash Cash, cash equivalents, and restricted cash-beginning of period Cash, cash equivalents, and restricted cash-end of period (1,040,361) 174,188 1171,121) 179,414 (800,228) 343,554 (21,455) 19.952) (38,084) (2,056,470) 580.795 36,897 (79,972) 126,486) (8,000) (5.843) (5,000) 1,659 (1,562.420) (3,000) (141) (1,458) (141) 43 (889,043) (1,569) (3,369) 11.569) (499,468) 1,979,206 17,673 4,709 (247,553) 15,482 3,585 1,979,206 38,433 28,550 4,088 15,482 9,169 48,547 1,754,035 1,264,388 1,028,728 2,293,116 19,067 52.252 281,830 334,082 2,050,277 1,959,034 334,082 2,293,116 542,492 615,690 268,114 65,968 334,082 $ $ $ $ Reconciliation of GAAP to Non-GAAP Measures (Unaudited, in thousands, except share and per share amounts) Three Months Ended January 31, 2021 2020 256,117 $ 10,553 Year Ended January 31, 2021 2020 659,848 $ 12.696 $ 101,853 27,892 75.971 GAAP income from operations Add: Stock-based compensation expense and related payroll taxes Charitable donation of common stock Acquisition-related expenses Non-GAAP income from operations 290,832 23,312 9,278 983.270 2.938 360,908 S $ 38,445 $ 88,667 s $ 260,393 $ 15.313 $ 671527 $ 21,750 101,853 27,892 75,971 GAAP net income attributable to common stockholders Add: Stock-based compensation expense and related payroll taxes - Charitable donation of common stock Acquisition-related expenses Undistributed earnings attributable to participating securities Non-GAAP net income - 2,938 290,832 23,312 9,278 789 995,738 212 365,401 26 43,231 3,555 101,276 $ $ $ $ $ Net income per share - basic and diluted: GAAP net income per share basic GAAP net income per share-diluted Non-GAAP net income per share - basic Non-GAAP net income per share-diluted S S 0.91 0.87 1.27 0.06 0.05 0.09 0.09 $ $ $ $ $ $ $ $ 2.37 2.25 3.51 3.34 S S 0.16 0.15 $ $ $ 0.37 0.35 1.22 287,598,299 276,719,764 283,853,654 233,641,336 GAAP weighted average shares used to compute net income per share basic Add: Non-GAAP unweighted adjustment for common stock issued in connection with IPO Non-GAAP weighted-average shares used to compute net income per share-basic 37,484,508 271,125,844 287,598,299 276,719,764 283,853,654 300,613,251 292,789,235 298,127,669 254,298,014 CAAP weighted-average shares used to compute net income per share-diluted Add: Non-GAAP unweighted adjustment for common stock issued in connection with IPO - Non-GAAP weighted average shares used to compute net income per share-diluted 37,484,508 291,782,522 300,613,251 292,789 235 298,127,669 $ 399,396 $ 36,554 $ 1,471,177 $ 151,892 Net cash provided by operating activities Less: Purchases of property and equipment Free cash flow (non-GAAP) - Net cash used in investing activities Net cash provided by financing activities (38,084) 113,808 s $ (21,455) 377941 (889,043) 1,754,035 19,952) 26,602 (3,369) 19.067 $ $ $ (79,972) 1,391,205 (1,562,420) 2,050,277 S $ $ $ $ (499,468) 615,690 S $